WHAT WE'RE UP AGAINST
Breast cancer has now become the most commonly diagnosed cancer worldwide, with around 2.3 million people diagnosed with the disease globally each year.
Breast cancer affects every person differently. Some cancers are aggressive, some are difficult to treat, and some people have limited treatment options. That's why continued research is urgently needed.
THE MISSION
At Breast Cancer Trials, we believe a future where no more lives are cut short by breast cancer is possible.
As Australia and New Zealand's largest independent breast cancer clinical trials research group, we help turn promising research ideas into real treatments for people affected by breast cancer. Every treatment available today first had to be tested in a clinical trial, and every treatment we need tomorrow will too.
When you host a Pink Bloom Party, you're helping fund the clinical trials research that gives people affected by breast cancer more treatment options, more hope and more time.
YOUR SUPPORT WILL HELP FUND
WHY SUPPORT US
Since 1978, Breast Cancer Trials has helped deliver breakthroughs that have improved survival rates, expanded treatment options, and reduced the side effects experienced by people undergoing breast cancer treatment.
Breast cancer trials research is the only way to get new and improved treatments to all Australians living with breast cancer.
Our work over the last 48 years has seen treatments like Herceptin, Exemestane, Letrozole and Tamoxifen become widely available, saving millions of lives.
But there is still so much more to do.
There is no shortage of promising ideas for preventing, treating and curing breast cancer. What is often missing is the funding needed to take those ideas into clinical trials and ultimately into the hands of doctors and patients.
Every Pink Bloom Party helps fund research that will bring us closer to a future where no more lives are cut short by breast cancer.
OUR RESEARCH
Breast cancer clinical trials research is a team effort – researchers, clinical trial participants and supporters working together to help ensure no more lives are cut short by breast cancer. Below are a few of our current clinical trials. To find out more about our life-saving research and the impact you can make register to host a Pink Bloom Party now. We look forward to seeing how you bloom this October!
OPTIMA Clinical Trial
Research Lead: Dr Belinda Kiely
The OPTIMA clinical trial is investigating if a simple test on tumour tissue can tell us if a patient may be spared chemotherapy and its short and long-term side effects without compromising their chance of survival.
EXPERT Clinical Trial
Research Lead: Dr Boon Chua
The EXPERT clinical trial is investigating whether a genomic test can identify women with good prognosis, early-stage breast cancer who can safely avoid radiation therapy and its side effects
NEO-N Clinical Trial
Research Lead: Dr Sherene Loi
The Neo-N clinical trial (Cohort-C) builds on earlier results which showed the benefit of using immunotherapy, which helps boost the body’s own immune system to fight the cancer, in combination with chemotherapy to treat early-stage triple negative breast cancer.
CAMBRIA-2 Clinical Trial
Research Lead: Dr Nicholas Zdenkowski
The CAMBRIA-2 clinical trial aims to find out if giving a new treatment known as a ‘selective estrogen receptor degrader’ is better at stopping breast cancer from coming back compared with the standard hormone treatments.
OLIO Clinical Trial
Research Lead: Dr Stephen Luen
The OLIO clinical trial aims to provide new treatment options for young women with hormone receptor (HR) positive, HER2 negative breast cancer.
